SciBase receives initial order for clinical study from Castle Biosciences

Contributed by: PR Newswire

Tags

SCIBASE

More Like This

SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30

SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million

SciBase receives first order in Austria

SciBase reaches milestone with over 400,000 tests sold with Nevisense

SciBase Expands Further Through European Market with First Sales Order to customer in Italy

SciBase announces sale of Nevisense to NIH (US)

Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami

SciBase: A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense.